Western herbalism
SpearmintMentha spicata
A milder mint with a long folk record for digestion and almost no gut trials; the one controlled study found no effect on reflux or sphincter pressure.
- Botanical name
- Mentha spicata
- Part used
- leaf
- Also called
- Garden mint, Common mint, Mentha viridis
- Used in
- Western herbalism
- Taken for
- Gas, Indigestion, Cramping and pain, Nausea
- Sold as
- tea, capsules, extract, fresh
What is meant by spearmint
Spearmint (Mentha spicata) is the mint most often used in cooking and tea around the Mediterranean and Middle East. Like peppermint it belongs to the Lamiaceae (mint) family, but its oil is dominated by carvone, a caraway-scented compound, where peppermint oil is dominated by menthol.
The leaf is used fresh, dried as a tea, or extracted. Supplement makers also sell a dried water extract standardized to rosmarinic acid, a polyphenol, and an essential oil. Gut products are usually the dried leaf or tea, alone or in a blend.
This entry is short on human data by necessity. Most published trials of spearmint are about hormones or memory, not digestion, and we have listed the few that touch the gut or establish a safety record.
In the traditions
Western herbalism
Ethnobotanical surveys describe spearmint as an everyday digestive herb in Mediterranean and Middle Eastern folk medicine. A survey of Lamiaceae species in Lebanon, which included a spearmint subspecies, found that the family was used mainly against gastrointestinal disorders and infections. A survey of the folk medicine of Lorestan Province in Iran ranked spearmint among the plants cited most often, in a region where most of the recorded plants were used for gastrointestinal, respiratory and skin problems. These are records of what communities report using, not of what trials have shown.
What the plant contains
The oil of spearmint is carvone-rich, with carveol, dihydrocarvone, dihydrocarveol and dihydrocarvyl acetate also present, according to a review of the oil. That review lists antimicrobial, antioxidant and anti-inflammatory activities for these compounds in laboratory work. One laboratory study tested mint oils against Helicobacter pylori bacteria in a dish: a carvone-type spearmint oil inhibited the reference strain at 15.6 to 31.3 mg/L, and carvone alone was among the more active single compounds (50% of clinical strains inhibited at 31.3 mg/L). Those are test-tube concentrations, and no trial has tested spearmint against H. pylori in people. The dried water extract sold as a supplement is standardized to rosmarinic acid instead.
What has been tested in people
We could not find a randomized trial of spearmint tea or leaf for any gut condition. The human data that touch the gut are indirect.
The most relevant study asked a narrow question. In a randomized, double-blind crossover study of healthy volunteers, a 500 mg dose of spearmint, a 0.5 mg flavoring dose and placebo were given with a pressure catheter in the esophagus. Spearmint did not change lower esophageal sphincter pressure (19.6 against 16.0 mmHg at the high dose, not significant) and did not change the number of reflux episodes. The high dose did raise symptom scores (0.35 against 0 at baseline, P = 0.03), which the authors attributed to direct irritation of the lining, not reflux. The study had no peppermint arm, so it does not compare the two mints.
In a randomized trial of 301 patients with nausea after surgery, inhaling a blend of ginger, spearmint, peppermint and cardamom oils lowered nausea scores against saline (P < 0.001), as did ginger oil alone, and fewer antiemetic drugs were requested. Because spearmint was one of four oils, the trial does not show what spearmint contributes.
Outside the gut, spearmint tea twice a day for 30 days lowered free and total testosterone in 42 women with polycystic ovary syndrome (P < 0.05), and an extract at 600 and 900 mg a day for 90 days produced no adverse hormone or lab changes in adults with memory complaints. Both are safety context, not gut results.
| Study | Dose | What it found |
|---|---|---|
| Randomized crossover study, healthy volunteers, esophageal pressure and pH PMID 10383511 | 500 mg or 0.5 mg single dose | Lower esophageal sphincter pressure and reflux episodes unchanged; high dose raised symptom scores (P = 0.03) without more reflux |
| Randomized trial, 301 patients with nausea after surgery (spearmint was one of four oils) PMID 22392970 | Inhaled ginger, spearmint, peppermint and cardamom blend | Nausea fell more than with saline (P < 0.001); fewer antiemetics requested |
| Randomized placebo-controlled trial, adults with age-associated memory impairment (safety analysis, not a gut trial) PMID 28286189 | 600 or 900 mg a day dried aqueous extract, 90 days | No severe adverse events; no changes in vital signs, blood chemistry, or FSH, LH and TSH |
| Randomized trial, 42 women with polycystic ovary syndrome (hormonal outcome, not a gut trial) PMID 19585478 | Spearmint tea twice a day, 30 days | Free and total testosterone lowered (P < 0.05); 41 of 42 completed |
Doses used in trials and traditional preparations
No dose has been tested for digestive complaints. The esophageal study gave single doses of 500 mg (high) and 0.5 mg (flavoring). A dried aqueous extract standardized to rosmarinic acid was given at 600 and 900 mg a day for 90 days in the safety trial, and the hormone trial used spearmint tea twice a day for 30 days. The tea (leaf steeped in hot water) is the form the trials and surveys describe. We could not find a European monograph or pharmacopoeial posology for spearmint leaf.
Treat these figures as a record of what was studied. Whether any amount of spearmint suits a particular person is a question for a clinician or pharmacist who knows their history.
Safety
Spearmint and its extracts are classed as Generally Recognized as Safe in the United States for use as a flavoring, and the safety trial of a dried aqueous extract (600 and 900 mg a day for 90 days in healthy adults) found no severe adverse events and no difference in reported events from placebo. In the esophageal study, six volunteers on the 500 mg dose reported symptoms, against one on placebo, without more reflux, and the authors attributed this to mucosal irritation. The hormone trial found lower testosterone with tea, while the extract trial found no change in FSH, LH or TSH, so the hormone question is not settled. We could not find a safety assessment of spearmint in pregnancy or breastfeeding, and no study in children. Food amounts are not the same as concentrated oil, which was not tested.
Drug interactions
We could not find a published interaction study of spearmint with any medicine, and the European herbal committee has not issued a monograph for it. Two data points are relevant: the extract trial found no change in thyroid-stimulating hormone or the pituitary hormones FSH and LH over 90 days, while the tea trial in women with polycystic ovary syndrome found lower testosterone and higher LH and FSH over 30 days. Anyone taking hormone-related medicines may see the second finding as relevant, and the evidence does not settle it. The catalog’s own drug rules are listed automatically on this page.
Products in the catalog with spearmint
These catalog entries list spearmint or one of its preparations among their active ingredients. Each page shows the amount on the label, the trials behind it and what buyers report.
From the herb to a product that fits you
Answer a few questions about your symptoms, routine and medicines, and the quiz names one product, with the reasons it won.
Take the quizRelated herbs
Questions people ask
Is spearmint the same as peppermint?
No. They are separate mints. Spearmint oil is rich in carvone, and peppermint oil in menthol, and the IBS trials of peppermint used peppermint oil capsules. Results for one cannot be assumed for the other.
Does spearmint cause heartburn?
In a crossover study of healthy volunteers, spearmint did not lower esophageal sphincter pressure or increase reflux episodes. A 500 mg dose did raise symptom scores in some people, which the authors put down to direct irritation. The study had no peppermint arm, so it does not compare the two.
Are there trials of spearmint for IBS or bloating?
We could not find any. The human trials of spearmint we found were about hormones and memory, with one study of esophageal pressure and one aromatherapy trial using a four-oil blend for nausea.
Does spearmint tea affect hormones?
In a 30-day trial of 42 women with polycystic ovary syndrome, spearmint tea twice a day lowered free and total testosterone and raised LH and FSH. A 90-day extract trial in adults with memory complaints found no change in FSH, LH or TSH. The two studies used different preparations and populations.
Sources
- Bulat R et al., "Lack of effect of spearmint on lower oesophageal sphincter function and acid reflux in healthy volunteers", Aliment Pharmacol Ther 1999;13(6) pubmed.ncbi.nlm.nih.gov/10383511
- Hunt R et al., "Aromatherapy as treatment for postoperative nausea: a randomized trial", Anesth Analg 2013;117(3):597-604 pubmed.ncbi.nlm.nih.gov/22392970
- Lasrado JA et al., "Safety and tolerability of a dried aqueous spearmint extract", Regul Toxicol Pharmacol 2017;86:167-176 pubmed.ncbi.nlm.nih.gov/28286189
- Grant P, "Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. A randomized controlled trial", Phytother Res 2010;24(2):186-188 pubmed.ncbi.nlm.nih.gov/19585478
- Zhang LL et al., "Bioactive properties of the aromatic molecules of spearmint (Mentha spicata L.) essential oil: a review", Food Funct 2022;13(6):3110-3132 pubmed.ncbi.nlm.nih.gov/35212344
- Piasecki B et al., "Composition and Anti-Helicobacter pylori Properties of Essential Oils Obtained from Selected Mentha Cultivars", Molecules 2023;28(15):5690 pubmed.ncbi.nlm.nih.gov/37570659
- Khoury M et al., "Report on the Medicinal Use of Eleven Lamiaceae Species in Lebanon and Rationalization of Their Antimicrobial Potential by Examination of the Chemical Composition and Antimicrobial Activity of Their Essential Oils", Evid Based Complement Alternat Med 2016 pubmed.ncbi.nlm.nih.gov/28053641
- Mehrnia M et al., "Ethnopharmacological studies of medicinal plants in central Zagros, Lorestan Province, Iran", J Ethnopharmacol 2021;280:114080 pubmed.ncbi.nlm.nih.gov/33798662